President & CEO

Co-founder and lead for PsychU (www.PsychU.org)

Otsuka and Lundbeck receive Complete Response Letter from U.S. FDA for sNDA of REXULTI® (brexpiprazole) in combination with sertraline for the treatment of adults with PTSD

Rare Kidney Disease Community Members Join American Kidney Fund and IgA Nephropathy Foundation on Capitol Hill to Champion Key Legislation

Bipolar Disorder Market Research Report 2025-2035 | Pharma Leaders Advance Bipolar Disorder Treatment with Targeted Therapies and Genomic Innovation

Schizophrenia Market Research and Forecast Report 2025-2034 | Emerging Therapies and Genetic Research Drive Growth with Bristol Myers Squibb, AstraZeneca, and Eli Lilly Leading

Associate Director, Scientific Communications - CNS

Otsuka Pharmaceutical Companies (U.S.) is seeking an Associate Director, Scientific Communications to manage the execution of the scientific and medical communications strategy for the CNS therapeutic area portfolio. This role involves overseeing the creation of core content assets, managing the global publications plan, and providing guidance to the medical writing team to ensure scientific accuracy and compliance.

VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

0.800000011920929

Associate Director, Scientific Communications, Hematology Oncology

Johnson & Johnson is a leader in healthcare innovation, dedicated to developing treatments and pioneering solutions for complex diseases. The Associate Director, Scientific Communications, Hematology Oncology will drive the development and dissemination of strategic scientific communications, overseeing medical communications vendors and providing editorial and writing support for assigned projects.

Associate Director, Scientific Communications, Hematology Oncology - Horsham, PA

Chief Financial Officer

STAT+: Xenon’s seizure drug study reads out soon. Here’s what to expect

New Enterprise Associates Portfolio

Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference

Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025

Associate Director, Scientific Communications

Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics. The Associate Director, Scientific Communications will support the development and execution of field medical and congress materials for epilepsy and neuropsychiatry programs, ensuring alignment with key Medical Affairs priorities.

President and CEO

Executive Vice President and CFO

Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge

Exelixis Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer

Exelixis reports zanzalintinib new drug application accepted for review by FDA

Associate Regulatory Scientific Communications Director

Exelixis is a biotech company that focuses on developing innovative cancer treatments. The Associate Regulatory Scientific Communications Director will lead content development for regulatory and clinical documents, ensuring high quality and compliance with regulatory standards.

President, CARVYKTI

Legend Biotech rises 16.6%

12 Health Care Stocks Moving In Monday's Pre-Market Session

Legend Biotech falls -10.5%

Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use

Associate Director, Global Scientific Communications, Medical Affairs

Legend Biotech is a global biotechnology company dedicated to treating and curing life-threatening diseases. The Associate Director will be responsible for the creation, management, and optimization of scientific content to support the medical strategy for lead BCMA CAR-T, cilta-cel, and enhance communication with healthcare professionals and stakeholders.

Founder and Chief Executive Officer

Chief Commercial Officer

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO)

Zenas’ MS drug reduces new brain lesion formation by 95% in Phase II trial

Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday

Zenas BioPharma CEO Leon O. Moulder Jr. Acquires 100,000 Shares

Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. The Associate Director, Scientific Communications will play an integral role in driving scientific communications across Zenas’ programs, focusing on publication planning, congress strategy, and developing scientific resources for Medical Science Liaisons.

Co-Founder & Chief Executive Officer

Associate Scientific Director, Medical Communications

Precision Medicine Group is a leader in delivering strategic scientific and medical communication solutions. They are seeking an Associate Scientific Director to ensure high-quality, evidence-based content that meets client objectives and translates science into clinical benefit.

CEO, Skeletal Dysplasias (QED Therapeutics)

CEO and Founder

BridgeBio Pharma Gets $135 Million Boost for Genetic-Disease Treatments

BridgeBio reports Q4 EPS ($1.00), consensus (67c)

Blue Owl, Genuine Parts, And Okta Are Among Top 10 Large Cap Losers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?

BridgeBio Pharma Raises $299 Million

Associate Director, Scientific Communications & Publications

BridgeBio is a pioneering company in biotech that focuses on developing life-changing medicines for patients with unmet needs. The Associate Director, Scientific Communications & Publications will lead the scientific communications strategy for endocrinology and collaborate with various teams to ensure effective messaging and publication execution.

Associate Director, Scientific Communications   Cns

Associate Director, Scientific Communications Cns in united states (1000+)

Associate Director, Scientific Communications - CNS

Associate Director, Scientific Communications, Hematology Oncology - Horsham, PA

Associate Director, Scientific Communications

Associate Regulatory Scientific Communications Director

Associate Director, Global Scientific Communications, Medical Affairs

Associate Director, Scientific Communications

Associate Scientific Director, Medical Communications

Associate Director, Scientific Communications & Publications